SCINOPHARM TAIWAN LTD
Overview
SCINOPHARM TAIWAN LTD is an active pharmaceutical ingredient (API) supplier with 71 active FDA Type II Drug Master Files, covering ABEMACICLIB; ALECTINIB HYDROCHLORIDE; ALPELISIB; ANASTROZOLE USP; APIXABAN; APREMILAST.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances SCINOPHARM TAIWAN LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
SCINOPHARM TAIWAN LTD holds 71 active (86 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ALECTINIB LAURYLSULFATEActive2026-06-23
- ALECTINIB HYDROCHLORIDEActive2025-12-29
- SEMAGLUTIDE FULL SIDE CHAINActive2025-12-10
- OLAPARIB (FORM A)Active2025-09-26
- ABEMACICLIBActive2025-06-27
- TUCATINIBActive2025-03-26
- ALPELISIBActive2024-10-29
- NELARABINEActive2023-11-29
- ENZALUTAMIDEActive2023-08-28
- CEDAZURIDINEActive2023-07-03
- APIXABANActive2022-12-30
- LIRAGLUTIDEActive2022-05-19
- OSIMERTINIB MESYLATEActive2021-12-24
- ELAGOLIX SODIUMActive2021-03-31
- IVACAFTORActive2020-12-28
Showing 15 of 86 Drug Master Files.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SCINOPHARM TAIWAN LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SCINOPHARM TAIWAN LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.